A clinical trial evaluating the safety and effectiveness of an investigational medication in patients with Mycosis Fungoides

Study Design:
Multi-center, open-label study of patients with stage IB-IVB Mycosis Fungoides
Patients will receive investigational medication by intravenous infusion.

Patients:
Men and women, who are 18 years of age or older
Diagnosis of stage IB-IVB Mycosis Fungoides
Patients must be intolerant to Bexarotene (Targretin ®) and one other standard therapy (phototherapy, systemic medications, external treatments)

If you are eligible to participate in this research study you will receive the following at no additional cost:

• Physical Exam
• Laboratory Testing
• Research Related Care
• Compensation for your time and effort

Please call 212-263-6881 or e-mail Judy Wang at dermpharm@med.nyu.edu for more information.